Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Aug;91(8):1085-6.
doi: 10.1136/bjo.2006.106930.

Interferon alpha eye drops: treatment of atypical lymphoid hyperplasia with secondary alopecia

Case Reports

Interferon alpha eye drops: treatment of atypical lymphoid hyperplasia with secondary alopecia

P T Finger et al. Br J Ophthalmol. 2007 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have no proprietary interest in any drugs used in this study.

Informed consent was obtained for publication of the person's details in this report.

Similar articles

Cited by

References

    1. Erickson B A, Harris G J, Enke C A.et al Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatment. Radiology. 1992 Oct 18563–70. - PubMed
    1. Polito E, Leccisotti A. Prognosis of orbital lymphoid hyperplasia. Greafes Arch Clin Exp Ophthalmol 1996234150–154. - PubMed
    1. Coupland S E, Hellmich M, Auw‐Haedrish C.et al Prognostic value of cell‐cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol 2004242130–145. - PubMed
    1. Finger P T. Topical chemotherapy for malignant conjunctival and corneal neoplasia. Br J Ophthalmol 200690807–809. - PMC - PubMed
    1. Boehm M D, Huang A J. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology 20041111755–1761. - PubMed